Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study
Authors:
- Yu Z BaggerYBYu Z Bagger
- László B TankóLTLászló B Tankó
- Peter AlexandersenPAPeter Alexandersen
- Henrik Bo HansenHHHenrik Bo Hansen
- Anette MøllgaardAMAnette Møllgaard
- Pernille RavnPernille Ravn
- Per QvistPQPer Qvist
- John A KanisJKJohn A Kanis
- Claus ChristiansenCCClaus Christiansen
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Does Hormone-Replacement Therapy Prevent Fractures in Early Postmenopausal Women?Journal of Bone and Mineral Research, 2002
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- The Effect of Postmenopausal Estrogen Therapy on Bone Density in Elderly WomenNew England Journal of Medicine, 1993
- Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture.BMJ, 1992
- Hip Fracture and the Use of Estrogens in Postmenopausal WomenNew England Journal of Medicine, 1987
- CYPROTERONE ACETATE, AN ALTERNATIVE GESTAGEN IN POSTMENOPAUSAL OESTROGEN/GESTAGEN THERAPYClinical Endocrinology, 1987
- BONE MASS AFTER WITHDRAWAL OF OESTROGEN REPLACEMENTThe Lancet, 1981
- Decreased Risk of Fractures of the Hip and Lower Forearm with Postmenopausal Use of EstrogenNew England Journal of Medicine, 1980
- BONE RESPONSE TO TERMINATION OF ŒSTROGEN TREATMENTThe Lancet, 1978